CIK 0001438533 · Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 262383102
- Phone
- 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- 424B5 Offering Prospectus
- 305B2 Other 305B2
- FWP Offering Free Writing Prospectus
- 4 Planned sale Director sold 4,500 shares at $46.65 ($209,925)
- 4 Planned sale Director sold 8,000 shares at $45.00 ($360,000)
- 4 Planned sale Chief Research Officer sold 2,763 shares at $43.95 ($121,434)
- 4 Planned sale Chief Legal Officer and GC sold 24,250 shares at an average $45.06 ($1,092,657)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 22,485 shares at an average $45.15 ($1,015,086)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 2,174 shares at $46.65 ($101,417)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 22,500 shares at $43.95 ($988,875)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 2,491 shares at an average $46.31 ($115,368)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 4 of 65 · 1,286 filings